News

AstraZeneca vs. KRKA: Supreme Court of Russia’s Decision Impact on Divisional Filing Strategy at RUPTO

On June 4, 2024, the Supreme Court of Russia ruled in favor of AstraZeneca (patentee) against KRKA (opponent) regarding the validity of AstraZeneca’s patent RU2746132 for «Forxiga» (INN: dapagliflozin), which is used to treat heart failure and chronic kidney disease in type 2 diabetic patients. This patent was extended by RUPTO based on «Forxiga’s» first marketing authorization, and remains valid until May 15, 2028.

This decision is obviously significant for AstraZeneca, which is currently involved in lawsuits against several generic manufacturers in Russia. Moreover, it holds substantial importance for the validity of approximately 600 other drug-related enforceable Russian patents granted on divisional applications.

By reversing the earlier IP Court decision, the Supreme Court thereby confirmed the legal correctness of RUPTO’s approach to acknowledging the priority dates of consecutive patent applications based on the first original parent application.

As a result, the divisional filing strategy at RUPTO remains as usual, maintaining a more convenient and innovator-friendly approach compared to potential alternative, which might have been appeared otherwise.

pat

Recent Posts

Kazakhstan marks a significant milestone in intellectual property: the registration of its 100,000th trademark.

The nation continues to break records in the realm of intellectual property. Recently, the National…

1 неделя ago

EAPO’s PPH Network: A Growing Global Collaboration

The EAPO has been actively engaging with other patent offices worldwide to establish PPH agreements,…

2 недели ago

Eduard Shablin, Partner at Patentica, participated in roving seminar of the Eurasian Patent Office in China

From March 17 to 21, a delegation from the Eurasian Patent Office (EAPO), together with…

4 недели ago

Revolutionary Impact of AI in the Ski Resort Industry

The full-scale implementation of artificial intelligence (AI) in the ski industry is transformative. Sber has…

1 месяц ago

Impressive Achievements of the Eurasian Patent Office in 2024

In 2024, the Eurasian Patent Office (EAPO) saw remarkable growth, receiving 3,252 Eurasian applications for…

1 месяц ago

New Patent Regulations in Ukraine: Key Changes and Considerations

As of September 18, 2024, the National Office of Intellectual Property and Innovations of Ukraine…

2 месяца ago